San Diego-based Viking Therapeutics marked itself as a serious competitor while in the weight loss drug industry in February following revealing promising knowledge from the mid-stage trial of experimental drug VK2735, which recommended it rivaled—and outperformed—Novo and Lilly drugs when provided for a weekly injection and in March the compan… Read More